Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
Gilead nears deal to buy Immunomedics for more than US$20 bln -WSJ
